For many UK start-ups in biotech and AI, selling doesn’t come naturally. Founders are often scientists, engineers, developers ...

The EU's sweeping new rules on the regulation of medicines has been one of the most bitterly contested pieces of legislation ...

Hungarian businesses have “great opportunities” in Mexico, said Foreign Minister Péter Szijjártó in Mexico City.

The Council has agreed its position on new rules that will make the EU’s pharmaceutical sector fairer and more competitive.

EU member states have adopted a controversial set of new measures governing the regulation of medicines at European level, ...

The global food grade alcohol market is entering a new era of growth, driven by diverse and increasing applications in ...

EYCORE - Emerging Polish Space Defence Company Becomes Key Player in Developing National Earth Observation Constellation ...

Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.

The deal includes a drug for systemic mastocytosis, a rare immunology disease, approved in the U.S. and the European Union under the brand names Ayvakit and Ayvakyt as well as an early-stage ...

These companies represent diverse enterprises, from corporate-risk mitigation to a snake-bite antidote to new hope for tracheotomy patients.” ...

This newsletter is a summary of the antitrust developments we think are most interesting to your business. Eliana Paredis (counsel based in ...